Correlation Between Regencell Bioscience and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regencell Bioscience Holdings and Moderna, you can compare the effects of market volatilities on Regencell Bioscience and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and Moderna.

Diversification Opportunities for Regencell Bioscience and Moderna

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Regencell and Moderna is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and Moderna go up and down completely randomly.

Pair Corralation between Regencell Bioscience and Moderna

Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to generate 1.52 times more return on investment than Moderna. However, Regencell Bioscience is 1.52 times more volatile than Moderna. It trades about 0.02 of its potential returns per unit of risk. Moderna is currently generating about -0.03 per unit of risk. If you would invest  1,333  in Regencell Bioscience Holdings on August 16, 2025 and sell it today you would lose (33.00) from holding Regencell Bioscience Holdings or give up 2.48% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Regencell Bioscience Holdings  vs.  Moderna

 Performance 
       Timeline  
Regencell Bioscience 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting technical and fundamental indicators, Regencell Bioscience may actually be approaching a critical reversion point that can send shares even higher in December 2025.
Moderna 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Regencell Bioscience and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regencell Bioscience and Moderna

The main advantage of trading using opposite Regencell Bioscience and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
The idea behind Regencell Bioscience Holdings and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges